Adcirca is approved to deal with a type of substantial blood pressure level in the lungs referred to as pulmonary arterial hypertension (PAH). The drug is authorised for use in males and ladies. PAH is a selected type of pulmonary hypertension that happens during the arteries of one's lungs.